Patient characteristics of the MDS/CMML cohort
CMML, chronic myelomonocytic leukemia, MDS/CMML
MYELODYSPLASTIC SYNDROME
Between January 2021 and August 2021, 8 patients with MDS/CMML after failure of HMAs were treated. The baseline characteristics and responses of the MDS cohort are shown in Table Baseline characteristics and responses of the MDS cohort (N = 8)Abbreviations: MDS, myelodysplastic syndrome; CMML, chronic myelomonocytic leukemia; IPSS-R, Revised International Prognostic Scoring System; CR, complete response; mCR, marrow complete response; HI, hematologic improvement; HI-E, HI with erythroid response; HI-N, HI with neutrophil response; HI-P, HI with platelet response